• Macro-aspartate aminotransferase in a healthy woman

• Lorubbio Maria

• Ognibene Agostino, Salvadori Benedetta, Fanelli Alessandra, Laffi Giacomo

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 378 ~ 381

• How does low-level viremia affect the prognosis of patients with chronic hepatitis B?

• Lee Hye-Won

• Kim Beom-Kyung

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 376 ~ 377

• Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adhe...

• Lee Seung-Bum

• Jeong Joon-Ho, Park Jae-Ho, Jung Seok-Won, Jeong In-Du, Bang Sung-Jo, Shin Jung-Woo, Park ...

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 364 ~ 375

• Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior s...

• Woo Hyun-Young

• Park Jun-Yong, Bae Si-Hyun, Kim Chang-Wook, Jang Jae-Young, Tak Won-Young, Kim Dong-Joon, ...

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 352 ~ 363

• Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma u...

• Lee Sun-Young

• Kim Seung-Seob, Chang Dong-Ryul, Kim Hye-Rim, Kim Myeong-Jin

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 340 ~ 351

• Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafe...

• Lee Cheol-Hyung

• Lee Yun-Bin, Kim Min-Seok, Jang Hee-Joon, Oh Hyun-Woo, Kim Sun-Woong, Cho Eun-Ju, Lee Kyun...

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 328 ~ 339

• Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 year...

• Chang Young

• Kim Jun-Il, Lee Bo-Ra, Kim Sang-Gyune, Jung Min-Jung, Kim Young-Seok, Jeong Soung-Won, Jan...

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 318 ~ 327

• Low-level viremia in patients undergoing antiviral therapy: Does it indicate time for a change?

• Kim Jung-Hee

• Sinn Dong-Hyun

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 315 ~ 317

• Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B p...

• Jang Byoung-Kuk

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 312 ~ 314

• Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?

• Kim So-Yeon

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 309 ~ 311

• Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcino...

• Han So-Jung

• Kim Do-Young

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 305 ~ 308

• Is liver biopsy still useful in the era of non-invasive tests?

• Lim Tae-Seop

• Kim Ja-Kyung

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 302 ~ 304

• Fecal microbiota transplantation in alcohol related liver diseases

• Shasthry Saggere Muralikrishna

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 294 ~ 301

• Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis

• Thuy Le Thi Thanh

• Hai Hoang, Kawada Norifumi

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 280 ~ 293

• Novel biomarkers for the management of chronic hepatitis B

• Inoue Takako

• Tanaka Yasuhito

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 261 ~ 279

• Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy

• Huang Chung-Feng

• Yu Ming-Lung

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 251 ~ 260

• Management of liver diseases during the pandemic of coronavirus disease-19

• Cho Ju-Yeon

• Kim Soon-Sun, Lee Young-Sun, Song Do-Seon, Lee Jeong-Hoon, Kim Ji-Hoon

• Clinical and Molecular Hepatology   2020  Volume.26  No.3 243 ~ 250